Alexander V. Kabanov - Curriculum Vitae#

Position:

• Professor and Head, Laboratory of Chemical Design of Bionanomaterials, M.V. Lomonosov Moscow State University (MSU), Moscow, Russia
  
• Co-Director, Carolina Institute for Nanomedicine, Mescal S. Ferguson Distinguished Professor and Director, Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, Univ. of North Carolina at Chapel Hill (UNC-Chapel Hill) Chapel Hill, NC, USA

Degrees:

• M.S. Chemistry, MSU, 1986
• Ph.D. Chemistry (cand. chem. science), MSU, 1987
• D.Sc. Biochemistry (doct. chem. science), MSU, 1990

Positions:

• 1987-1997 Research Fellow (Junior, Senior, and Leading), Faculty of Chemistry, MSU
  
• 1988-1993 Head, Laboratory and Department of Biopolymers, All-Russian Center of Molecular Diagnostics and Therapy
  
• 1994-2001 Associate Professor, Univ. of Nebraska Medical Center (UNMC)
  
• 2001-2012 Professor of Pharmaceutical Sciences, UNMC
  
• 2002-pres. Professor, School of Chemistry, MSU
  
• 2004-2012 Parke-Davis Endowed Chair in Pharmaceutics, UNMC
  
• 2004-2012 Founder & Director, Center for Drug Delivery and Nanomedicine, UNMC
  
• 2008-2012 Director, NIH Center for Biomedical Research Excellence, UNMC
  
• 2010-pres. Professor and Head, Laboratory of Chemical Design of Bionanomaterials, MSU
  
• 2012-pres. Mescal S. Ferguson Distinguished Professor, UNC-Chapel Hill
  
• 2012-pres. Director, Center for Nanotechnology in Drug Delivery, UNC-Chapel Hill
  
• 2012-pres. Co-Director, Carolina Institute for Nanomedicine, UNC-Chapel Hill

Selected Honors:

• 1988 Lenin Komsomol Prize
• 1991 USSR Medal “For Valiant Labor” (by Pres. M. Gorbachev)
• 1995 NSF CAREER award; 2003 NSF Special Creativity Award
• 2007 Univ. NE Outstanding Research and Creative Activity award
• 2009 UNMC Scientist Laureate
• 2010 Russian “Megagrant”

Other:

• 1994-pres. co-founder, BOD & SAB, Supratek Pharma, Inc., Montreal, Canada
• 2005-2011, co-founder, partner, BOD & CSO, InnovaForm Technologies, LLC, Philadelphia, PA
• 2011-, founder, Neuro10-9 Inc., Chapel Hill, NC.

Editorial Boards:

J. Contr. Rel., J. Bioact. Comp. Pol., AAPS J.; Adv. Drug Del. Rev.; Bioconj. Chem., J. Pharm. Sci., Int. J. Nanomed.; J. Neuroimmune Pharmacol. Grants review: NIH, NSF, PRF, ESF, ISF, Australian Res. Council, Canadian Found. Innovation, chair (2006-08) NIH BMBI study section; NCI CCNE panel, Japan WPI Res. Center.